Correlation Between Werewolf Therapeutics and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and C4 Therapeutics, you can compare the effects of market volatilities on Werewolf Therapeutics and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and C4 Therapeutics.
Diversification Opportunities for Werewolf Therapeutics and C4 Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Werewolf and CCCC is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and C4 Therapeutics
Given the investment horizon of 90 days Werewolf Therapeutics is expected to under-perform the C4 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Werewolf Therapeutics is 1.23 times less risky than C4 Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The C4 Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 385.00 in C4 Therapeutics on October 20, 2024 and sell it today you would earn a total of 9.00 from holding C4 Therapeutics or generate 2.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Werewolf Therapeutics vs. C4 Therapeutics
Performance |
| Timeline |
| Werewolf Therapeutics |
| C4 Therapeutics |
Werewolf Therapeutics and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Werewolf Therapeutics and C4 Therapeutics
The main advantage of trading using opposite Werewolf Therapeutics and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |